Skip to content

Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact

Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02537587
Acronym
Solstice
Enrollment
12
Registered
2015-09-01
Start date
2014-01-31
Completion date
2014-03-31
Last updated
2015-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Blood glucose, Blood insulin, Humans, Postprandial, Carbohydrate, Protein, Resistant starch, Sugar

Brief summary

The purpose of this study was to determine the effect of changing the amounts of resistant starch, whey protein and sugar on the blood glucose and insulin responses elicited by energy bars. The investigators also compared the glucose and insulin responses to the rates at which the food bars were digested in-vitro (in the test tube). The investigators thought increasing resistant starch and reducing sugar would reduce the glucose and insulin responses, and that adding protein would reduce glucose and increase insulin. The investigators also thought the glucose and insulin responses in people would be related to the rate of digestion of the food bars in-vitro.

Interventions

67g of control bar

86g of control bar

OTHER15/0

66g of experimental bar 15/0

OTHER15/0LS

84g of experimental bar 15/0LS

OTHER15/5

75g of experimental bar 15/5

OTHER10/5

72g of experimental bar 10/5

OTHER10/10

80g of experimental bar 10/10

Sponsors

PepsiCo Global R&D
CollaboratorINDUSTRY
Glycemic Index Laboratories, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index 20.0 to 34.9 kg/m² * Fasting serum glucose \<7.0mmol/L * Non-smoker

Exclusion criteria

* Known to have diabetes * Use of medications or presence of a medical condition considered by the principal investigator to increase risk to the participant or affect the results * Known food allergy of any kind

Design outcomes

Primary

MeasureTime frame
Incremental area under the blood glucose response curveFor 3 hours after consuming each test meal

Secondary

MeasureTime frameDescription
Incremental area under the serum insulin response curveFor 3 hours after consuming each test meal
Incremental area under the blood glucose response curveFor 2 hours after consuming each test meal
Insulin:Glucose area under the curve ratioFor 3 hours after consuming each test mealOutcome 2 (incremental area under the insulin response curve for 3 hours) divided by Outcome 1 (incremental area under the glucose response curve for 3 hours)
Insulinogenic index30 minutes after consuming each test mealI30 divided by G30; where I30 is the serum insulin increment at 30 minutes and G30 is the blood glucose increment at 30 minutes; and where increment is defined as the concentration at 30 minutes minus the fasting concentration.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026